MetaCap

Henry Schein Inc. (HSIC)

NASDAQ: HSICHealth CareMedical SpecialitiesUSD

83.52-1.28 (-1.51%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HSIC stock chart

Technical analysis

Key statistics

All statistics
52-week range
68.70 – 92.18
Day range
83.20 – 86.31
Volume / Avg
1.31M / 1.33M
Beta
—

52-week range

$68.70$92.18

HSIC stock today

Henry Schein (HSIC) closed at $83.52 on Nov 20, down 1.51% (-$1.28), versus the S&P 500's 3.70% decline. Shares are 9.4% below their 52-week high of $92.18, set on Aug 4, 2026 and 21.6% above the 52-week low of $68.70, in the middle of the past year's range. HSIC is up 10.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 13.8%.

At 22.9x trailing earnings, Henry Schein trades in line with the peer-group median of 24.8x. Its forward P/E of 13.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Henry Schein

Company profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.

Industry
Medical Specialities
CEO
Mr. Andrea Albertini
Headquarters
Melville, NY
Employees
25,000
IPO year
1995

Financial highlights

Full financials

In fiscal 2025, Henry Schein generated $13.18 billion in revenue, up 4.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $398.0 million (+2.1% year over year), for a net margin of 3.0% versus a median of 4.0% in the prior 5 years. Gross margin was 31.1% (down from 31.7%) and operating margin 5.0%.

Henry Schein annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$13.18B$12.67B$12.34B$12.65B$12.40B
Growth+4.03%+2.71%-2.44%+1.98%+22.55%
Net income$398.00M$390.00M$416.00M$538.00M$631.00M
EPS (diluted)$3.27$3.05$3.16$3.91$4.45

Analyst forecast

Forecast

Consensus (16 analysts)

buy

Avg. price target

$96.87+15.98%

  • Strong buy 4
  • Buy 4
  • Hold 7
  • Sell 1
  • Strong sell 0

Target range

Low $68.00High $110.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$1.06 vs $1.34
Surprise
-20.90%

HSIC news

All HSIC news

Henry Schein peers

Health Care sector
HSIC peer companies
CompanyPrice% ChgMarket capCompare
MOHMolina Healthcare Inc198.39-2.43%$10.36Bvs HSIC
OSCROscar Health Inc. Class A24.73-5.50%$7.68Bvs HSIC
RDNTRadNet Inc.69.71+0.29%$5.49Bvs HSIC
CONConcentra Group Holdings Parent Inc.41.84+0.94%$5.26Bvs HSIC
CAICaris Life Sciences Inc.17.58-5.18%$5.04Bvs HSIC
GRALGRAIL Inc.99.25-5.33%$4.46Bvs HSIC
BLLNBillionToOne Inc. Class A89.92-0.31%$4.30Bvs HSIC
CDNACareDx Inc.70.00-2.67%$3.68Bvs HSIC

Indexes, lists and sector

Henry Schein stock FAQ

What is Henry Schein's stock price today?

HSIC last traded at $83.52 as of Nov 20, 4:00 PM EST, down 1.51% on the day. Prices are delayed at least 15 minutes.

Does Henry Schein pay a dividend?

No. Henry Schein does not currently pay a regular cash dividend.

What is HSIC's P/E ratio?

HSIC trades at a trailing P/E ratio of 22.88 and a forward P/E of 13.91, compared with a median of 24.8 for its closest peers.

Is Henry Schein in the S&P 500?

Yes. Henry Schein (HSIC) is a constituent of the S&P 500 index.

Who is Henry Schein's CEO?

Mr. Andrea Albertini is the chief executive officer of Henry Schein Inc., which has about 25,000 employees.

Has HSIC ever split its stock?

Yes. The most recent HSIC stock split was a 1275-for-1000 split on Feb 8, 2019, one of 3 splits on record.

What is the HSIC 52-week high?

The 52-week high for HSIC is $92.18 and the 52-week low is $68.70. The stock is currently 9.4% below its high.

Compare HSIC